文献速递乳房整形与再造美容整形

基于720枚乳房假体包膜开发并验证包膜挛缩诊断性组织病理学评分系统

Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules.
PubMed 文献 · Aesthet Surg J · 2024-01-01

研究基于720枚乳房假体包膜活检,用多变量逻辑回归筛选与包膜挛缩相关的组织学参数,分别建立隆乳与再造的专用组织病理学评分系统。隆乳评分系统含4项参数、最高26分,AUC 81%、MAE 0.8%;再造评分系统含3项参数、最高19分,AUC 72%、MAE 7.1%。作者认为该评分系统可客观、可重复、准确地评估包膜挛缩严重程度。

要点

  • 隆乳评分系统含胶原层厚度、纤维排列、炎性浸润、钙化4项参数,最高26分,AUC 81%、MAE 0.8%。
  • 再造评分系统含纤维排列、胶原层细胞密度、炎性浸润3项参数,最高19分,AUC 72%、MAE 7.1%。
  • 作者提出该评分系统可用于临床确认包膜挛缩诊断、研究及假体厂商与保险机构。

核心结论

  • 新的组织病理学评分系统为包膜挛缩严重程度提供客观、可重复且准确的评估,作者提出其可作为临床诊断确认、研究及假体厂商与保险机构的有价值工具。

研究设计与样本

  • 研究使用乳房假体包膜活检组织,针对隆乳术后与再造术后患者分别开发组织病理学评分系统。
  • 共纳入来自542例患者的720枚活检。
  • 对10项组织学参数行多变量逻辑回归,筛选与包膜挛缩最相关的参数,显著参数(P < .05)纳入评分系统并赋权重分(1-10)。
  • 通过曲线下面积(AUC)和平均绝对误差(MAE)评估验证效果。

主要发现

  • 隆乳评分系统纳入4项参数:胶原层厚度、纤维排列、炎性浸润、钙化,合计最高分26分。
  • 隆乳评分系统的AUC为81%、MAE为0.8%,被认为强。
  • 再造评分系统纳入3项参数:纤维排列、胶原层细胞密度、炎性浸润,合计最高分19分。
  • 再造评分系统的AUC为72%、MAE为7.1%,被认为良好。

关键数值与推荐

  • 隆乳评分系统:4项参数,最高26分,AUC 81%,MAE 0.8%。
  • 再造评分系统:3项参数,最高19分,AUC 72%,MAE 7.1%。
  • 参数筛选标准为多变量逻辑回归P < .05。
  • 权重分范围为1-10。

临床怎么用

  • 作者提出这些新型评分系统可作为确认包膜挛缩诊断的有价值工具,适用于临床环境、研究以及需要确认包膜挛缩诊断的假体厂商与保险机构。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Capsular contracture is traditionally evaluated with the Baker classification, but this has notable limitations regarding reproducibility and objectivity. OBJECTIVES: The aim of this study was to develop and validate procedure-specific histopathological scoring systems to assess capsular contracture severity. METHODS: Biopsies of breast implant capsules were used to develop histopathological scoring systems for patients following breast augmentation and breast reconstruction. Ten histological parameters were evaluated by multivariable logistic regression to identify those most associated with capsular contracture. Significant parameters (P < .05) were selected for the scoring systems and assigned weighted scores (1-10). Validation was assessed from the area under the curve (AUC) and the mean absolute error (MAE). RESULTS: A total of 720 biopsies from 542 patients were included. Four parameters were selected for the augmentation scoring system, namely, collagen layer thickness, fiber organization, inflammatory infiltration, and calcification, providing a combined maximum score of 26. The AUC and MAE for the augmentation scoring system were 81% and 0.8%, which is considered strong. Three parameters were selected for the reconstruction scoring system, namely, fiber organization, collagen layer cellularity, and inflammatory infiltration, providing a combined maximum score of 19. The AUC and MAE of the reconstruction scoring system were 72% and 7.1%, which is considered good. CONCLUSIONS: The new histopathological scoring systems provide an objective, reproducible, and accurate assessment of capsular contracture severity. We propose these novel scoring systems as a valuable tool for confirming capsular contracture diagnosis in the clinical setting, for research, and for implant manufacturers and insurance providers in need of a confirmed capsular contracture diagnosis.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Larsen A, Timmermann AM, Kring M, et al. Development and Validation of a Diagnostic Histopathological Scoring System for Capsular Contracture Based on 720 Breast Implant Capsules. Aesthet Surg J. 2024. PMID: 38429010. doi:10.1093/asj/sjae050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。